ZOLEDRONIC ACID IN BONE METASTASES FROM BREAST CANCER
- 作者: Snegovoy A.1, Kononenko I.1, Manzyuk L.1, Selchuk V.1
-
隶属关系:
- N.N. Blokhin Russian Cancer Research Center
- 期: 卷 26, 编号 11 (2015)
- 页面: 62-65
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116445
- ID: 116445
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The use of bone remodeling markers is of great importance for evaluating the efficiency of bone metastases in malignant tumors. It is a convenient and safe method that is essential for conducting clinical trials.
全文:
作者简介
A. Snegovoy
N.N. Blokhin Russian Cancer Research Center
Email: drsneg@gmail.com
Candidate of Medical Sciences
I. Kononenko
N.N. Blokhin Russian Cancer Research CenterCandidate of Medical Sciences
L. Manzyuk
N.N. Blokhin Russian Cancer Research CenterProfessor
V. Selchuk
N.N. Blokhin Russian Cancer Research CenterProfessor
参考
- Kohno N., Aogi K., Minami H. et al. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastasis from breast cancer: a randomised, placebo-controlled trial // J. Clin. Oncol. - 2005; 23: 3314-21.
- Saad F., Gleason D., Murray R. et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormonerefractory prostate cancer // J. Natl. Cancer Inst. - 2004; 96: 879-82.
- Аполихин О.И., Сивков А.В., Ощепков В.Н. и др. Эффективность золедроновой кислоты у больных с костными метастазами рака предстательной железы. Приложение к журналу «Андрология и генитальная хирургия». Материалы Международного конгресса по андрологии 28-31 мая 2009. Сочи, ОК «Дагомыс» УД Президента РФ.
- Кулиева И.Э., Бесова Н.С. Опыт применения золедроновой кислоты (препарат Резорба) для лечения больных с костными метастазами // Эффективная фармакотерапия. Онкология, Гематология и Радиология. -2012; 4.
- Lipton A., Cook R., Major P. et al. Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity // The Oncologist. - 2007; 12: 1035-43.
- Seibel M., Lang M., Geilenkeuser W.-J. Interlaboratory Variation of Biochemical Markers of Bone Turnover // Clin. Chem. - 2001; 47: 1443-50.
- Leeming D., Koizumi M., Qvist P. et al. Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers // Biomarkers in Cancer. - 2011; 3: 15-23.
补充文件
